Skip to main content
Equibles

Patrick (Pat) Sullivan

Harrow, Inc. (HROW)

Equibles does not estimate personal net worth.

About Patrick (Pat) Sullivan

Patrick (Pat) Sullivan has spoken on 2 earnings calls across 1 company, most recently for Harrow, Inc. on August 11, 2026. Harrow, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Harrow, Inc. includes Francis W. Mullery (CEO), Frank Mullery (CEO), John P. Saharek (CEO) and 7 others.

Patrick (Pat) Sullivan on recent calls

“Before turning to Vivi, I'll briefly discuss what the pending Tervaya transaction means for our dry eye franchise. Vivi remains the cornerstone of that franchise.”
Other, Second Quarter 2026 Earnings Conference Call and Webcast ·
“I will detail the commercial execution across our portfolio. The thread that runs through every one of these slides is exactly the same. Demand is accelerating, access is improving, and our scaled commercial organization is now actively converting that demand into revenue.”
Other, Harrow, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Harrow, Inc.

Recent activity